The Influence of Remote Ischemic Preconditioning on Acute Kidney Injury After Cardiac Surgery
1 other identifier
interventional
120
1 country
1
Brief Summary
Acute kidney injury is associated with cardiopulmonary bypass during heart surgery and its pathogenesis is similar to that of ischemia-reperfusion injury. Remote ischemic preconditioning attenuates myocardial ischemia-reperfusion injury in patients undergoing coronary bypass surgery. The investigators hypothesize that such preconditioning reduces the incidence of acute kidney injury associated with cardiopulmonary bypass.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Nov 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 9, 2009
CompletedFirst Posted
Study publicly available on registry
January 13, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedNovember 17, 2021
November 1, 2021
1.3 years
January 9, 2009
November 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of acute kidney injury, after surgery, as defined by elevation in serum creatinine greater than or equal to 0.3 mg/dl.
48 hours after surgery.
Secondary Outcomes (2)
Oliguria.
12 hours after surgery.
Incidence of acute kidney injury as defined by post-operative elevation in NGAL.
3 hours after cardiopulmonary bypass.
Study Arms (2)
Preconditioning
ACTIVE COMPARATORControl
NO INTERVENTIONStandard clinical management during cardiac surgery.
Interventions
Three 5-minute intervals of leg ischemia induced by tourniquet inflation, prior to initiation of cardiopulmonary bypass.
Eligibility Criteria
You may qualify if:
- Patient undergoing heart surgery on cardiopulmonary bypass.
You may not qualify if:
- Known peripheral vascular disease of the lower extremities associated with active skin necrosis or infection.
- End-stage renal disease.
- Inability to give informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Robert Kramer, MDlead
- MaineHealthcollaborator
Study Sites (1)
Maine Medical Center
Portland, Maine, 04102, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert F Zimmerman, MD
MaineHealth
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Thoracic Surgery, MD
Study Record Dates
First Submitted
January 9, 2009
First Posted
January 13, 2009
Study Start
November 1, 2008
Primary Completion
March 1, 2010
Study Completion
May 1, 2010
Last Updated
November 17, 2021
Record last verified: 2021-11